1Joseph Oyepata Simeon,2 Builders Modupe,3 Joseph Opeyemi Tosin, 4Famojuro Tayo Ibukun,
5 Ogira Johnson Ogwuche,6 Moses Femi Daniel,7 Musa Tabitha Lubo
1,2Department of Pharmacology and Toxicolology, Faculty of Pharmaceutical Sciences, Bingham University, Nasarawa State, Nigeria
3Department of Pharmacy, University College Hospital, Ibadan, Oyo State, Nigeria
4Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Bingham University, Nasarawa State, Nigeria
5Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Bingham University, Nasarawa State, Nigeria
6May Institute Behavioural Health Services, Boston Massachusetts, USA
7Department of Pharmacognosy, Faculty of Pharmacy, Gombe State University, Gombe State, Nigeria
DOI : https://doi.org/10.47191/ijmra/v4-i2-13Google Scholar Download Pdf
ABSTRACT:
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus. The virus that causes COVID-19 spreads mainly when an infected person is in close contact with another person. The aim of this study is to determine the effect of COVID-19 on different countries, using USA as comparism factor. Ninety four countries were selected based on their continents, countries and cases of infection. Data from each country were obtained from United Nations Geoscheme and WHO and were analyzed and compared to that of the United State of America (USA). Data analyzed revealed that most countries in Africa appears to be least affected by the virus. Data also revealed that many countries have been able to understand and manage the spread and infectivity of the virus compared to the USA. Result from the study also showed that the many countries have been able to improve on managing the infection when compared to USA mortality. This may be due to among other factors a more robust immune response, herd immunity and united approach in the management of the disease. The result also helps to provide insight as to how significant developing and providing vaccine may be to this part of the world. Result from the study suggests that while Africa has a better immunity for the virus, there seems to be improvement the management of disease by other continent.
KEYWORDSAfrica, USA, COVID-19, countries, continent
REFERENCES
1) Virus Taxonomy. Release. International Committee on Taxonomy of Viruses (ICTV). March 2019. Archived from the original on 2018-03-04. Retrieved 2020-01-24
2) www.who.int/emergencies/diseases/novel-coronavirus-2020
3) Virus Taxonomy: Release". International Committee on Taxonomy of Viruses (ICTV). 2019.
4) Giaimo C. The Spiky Blob Seen Around the World. The New York Times. 2020. Page 1-12.
5) International Committee on Taxonomy of Viruses (ICTV). October 2018. Archived from the original on 2019-05-14. Retrieved 2020-01-24.
6) International Committee on Taxonomy of Viruses (ICTV). Retrieved 2020-01-24.
7) Fan Y, Zhao K, Shi ZL, Zhou P. Bat Corona viruses in China. Viruses. 2019.11 (3): 210-223.
8) Cherry, J, Demmler-Harrison GJ, Kaplan SL.; Steinbach WJ, Hotez PJ. Feign and Cherry's Textbook of Pediatric Infectious Diseases. Elsevier Health Sciences. 2017. p. PT6615. ISBN 978-0-323-39281-5.
9) Woo PC, Huang Y, Lau SK, Yuen KY. Corona virus genomics and bioinformatics analysis. Viruses. 2010. 2 (8): 1804–20.
10) Almeida JD, Berry DM, Cunningham CH, Hamre D, Hofstad MS, Mallucci L, McIntosh K, Tyrrell DA . Virology: Corona viruses. Nature. 1968. 220 (5168): 265-278.
11) https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant.html
12) Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". Lancet. 2020. 395 (10223): 507–513
13) Symptoms of Coronavirus". U.S. Centers for Disease Control and Prevention (CDC). 13 May 2020. Archived from the original on 17 June 2020. Retrieved 18 June 2020.
14) ArcGIS. Johns Hopkins University. Retrieved 12 January 2021.
15) Q&A on coronaviruses (COVID-19)". World Health Organization (WHO).
16) Nussbaumer-Streit B, Mayr V, Dobrescu AI, Chapman A, Persad E, Klerings I, et al. "Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review". The Cochrane Database of Systematic Reviews. 2020. 4: CD013574.
17) https://www.worldometers.info/coronavirus/11 January 2021
18) Transmission of COVID-19". European Centre for Disease Prevention and Control. Retrieved 6 December 2020.
19) Ye Q, Wang B, Mao J. "The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19". The Journal of Infection. 2020. 80 (6): 607–613.
20) Bénézit, François; Le Turnier, Paul; Declerck, Charles; Paillé, Cécile; Revest, Matthieu; Dubée, Vincent; Tattevin, Pierre. "Utility of hyposmia and hypogeusia for the diagnosis of COVID-19". The Lancet Infectious Diseases. 2020. 20 (9): 1014–1015.
21) Furukawa NW, Brooks JT, Sobel J . "Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic". Emerging Infectious Diseases. 2020. 26 (7).
22) https://reliefweb.int/report/world/analyzing-africa-s-second-wave-covid-19.
23) Litman GW, Cannon JP, Dishaw LJ. "Reconstructing immune phylogeny: new perspectives". Nature Reviews. Immunology. 2005. 5 (11): 866–79.
24) Joseph OS. and Joseph OT. Hepatoprotective activity of ethanol stem extract of Homalium letestui against thioacetamide-induced liver injury. The Nigerian Journal of Pharmacy. 2018. Vol. 52 (1). Page 67-74.
25) Joseph O. S., Jude E.O and Joseph O. T. Hepatoprotective activity of extract of Homalium Letestui stem against carbon tetrachloride-induced liver injury. Advance Herbal Medicine. 2018. Vol 4(4), Page 1-11.
26) Restifo NP, Gattinoni L. "Lineage relationship of effector and memory T cells". Current Opinion in Immunology. 2013. 25 (5): 556–63.
27) Kurosaki T, Kometani K, Ise W. "Memory B cells". Nature Reviews. Immunology. 2015. 15 (3): 149–59.
28) Boyton RJ, Openshaw PJ. "Pulmonary defences to acute respiratory infection". British Medical Bulletin. 2002. 61 (1): 1–12.
29) Joseph OS, Joseph OT, Musa TL and Oyepata P J. Histological evaluation of the nephroprotective activity of the ethanol stem extracts of Homalium letestui in Gentamicin – induced albino rats injury, using various staining techniques. Global Scientific Journal. 2020. Volume 7, Issue 8. Page 1065-1087.
30) Joseph OS, Builders M., Emem EU and Joseph OT. Effect of ethanol leaf extract of Cassia angustifolia extracts on liver of wister rats. Global Scientific Journal. 2019. Volume 8, Issue 9. Page 1112-11120.
31) Joseph OS., Builders M, Emem EU and Joseph OT. Effect of ethanol leaf extract of cassia angustifolia extract on kidney of wister rats. Global Scientific Journal. 2019. Volume 8, Issue 9. Page 1023-1031.
32) Agerberth B, Gudmundsson GH. "Host antimicrobial defence peptides in human disease". Current Topics in Microbiology and Immunology. 2006. 306: 67–90.
33) Joseph O. T, Obianime. A. W., Siminialaye M. I., Joseph O. S., Anyanwu C. and Musa T. L. Clinical study on the effect of Moringa oleifera on serum level of glucose and triglyceride in subjects taken tenofovir, lamivudine and efavirenz combination regimen. European Scientific Journal. 2019. Vol.15, (.21). Page 280 -293.
34) Moreau JM, Girgis DO, Hume EB, Dajcs JJ, Austin MS, O'Callaghan RJ. "Phospholipase A(2) in rabbit tears: a host defense against Staphylococcus aureus". Investigative Ophthalmology & Visual Science. 2001. 42 (10): 2347–54.
35) Wertheim JO, Chu DK, Peiris JS, Kosakovsky Pond SL, Poon LL. A case for the ancient origin of corona viruses. Journal of Virology. 2013. 87 (12): 7039–45.
36) Novel Corona virus (2019-nCoV) situation reports - World Health Organization (WHO) 16) 2019 Novel Corona virus (2019-nCoV) in the U.S. -. U.S. Centers for Disease Control and Prevention (CDC).
37) Novel corona virus (2019-nCoV) - Australian Government Department of Health 19)
38) Maimuna Majumder and Kenneth D. Mandl. Early Transmissibility Assessment of a Novel Corona virus in Wuhan, China - Harvard University - Computational Health Informatics Program 2020.
39) Imperial College London. Report 3: Transmissibility of 2019-nCoV – 25, 2020.
40) Joseph OS, Builders M, Joseph OT, Zubairu SA, Musa T. and Oyepata p.j. Sub-acute toxicity study of ethanol leaf extract of Ocimum canum on the kidney of wistar rats. African Journal of Pharmaceutical Research & Development. 2019. Vol. 11 No.1. Page 1-7.
41) Joseph OS, Builders M, Joseph OT, Zubairu SA, Musa T. and Oyepata PJ. Sub-acute toxicity study of ethanol leaf extract of Ocimum canum on brain, lungs, stomach and spleen of wister rats. African Journal of Pharmaceutical Research & Development. 2019. Vol. 11 No.1. Page 35-42.
42) Babraham institute (2020). Charting immune system development in sub-Saharan African
43) Litman GW, Cannon JP, Dishaw LJ. Reconstructing immune phylogeny: new perspectives. Nature Reviews. Immunology. 2020. 5 (11): 866–79.
44) Joseph O. S., Builders M., Joseph O. T., Sabastine A. Z. Assessing differential impacts of COVID-19 on African countries: A comparative study. International Journal of Research and Innovation in Applied Science. 2020.Vol. 5, Issue 5. Page 197-203.
45) Joseph OS, Musa TL, Joseph OT, Ibhafidon I. The Dynamics of Differential Impacts of COVID-19 on African Countries Compared to Other Parts of the World. International Journal of multidisciplinary research and analysis. 2020.Volume 03 Issue 11. Page 185-198.
46) Builders M., Joseph OS, Timothy OO, Philip B. (2020). Antimalarial Drugs and COVID -19. Sumerianz Journal of Medical and Healthcare. Vol. 3, No. 12, pp. 111-116.
47) Joseph OS, Builders M, Joseph OT, Zubairu SA, Musa T. and Oyepata PJ. Sub-acute toxicity study of ethanol leaf extract of Ocimum canum on brain, lungs, stomach and spleen of wister rats. African Journal of Pharmaceutical Research & Development 2019. Vol. 11 No.1. Page 35-42.
48) Joseph OS, Joseph OT, Musa TL and Oyepata PJ. Histological evaluation of the nephroprotective activity of the ethanol stem extracts of Homalium letestui in Gentamicin – induced albino rats injury, using various staining techniques. Global Scientific Journal. 2019. Volume 7, Issue 8. Page 1065-1087.
49) Restifo NP, Gattinoni L. Lineage relationship of effector and memory T cells. Current Opinion in Immunology. 2013. 25 (5): 556–63.
50) Kurosaki T, Kometani K, Ise W. Memory B cells. Nature Reviews. Immunology. 2015. 15 (3): 149–59.
VOLUME 04 ISSUE 02 FEBRUARY 2021
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 07 Issue 12 (December 2024).
PUBLICATION DATES:
1) Last Date of Submission : 26 December 2024 .
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.